<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>心血管出版物</title><link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_campaign=pubmed-2&amp;ff=20230924203716&amp;utm_medium=rss&amp;v=2.17.9.post6+ 86 293ac&amp;fc=20230708114047&amp;utm_source=Chrome&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC -<description>心血管亮点：PubMed 的最新结果</description><atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_campaign=pubmed-2&amp;ff=20230924203716&amp;utm_medium=rss&amp;v=2.17.9.post6+86293ac&amp;fc=20230708114047&amp;utm_source=Chrome&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-" rel="self"></atom:link><docs> http://www.rssboard.org/rss-specification</docs><generator> PubMed RSS 源 (2.17.9.post6+86293ac)</generator><language> zh</language><lastbuilddate> 2023 年 9 月 25 日星期一 00:37:18 +0000</lastbuilddate><pubDate> Sun, 24 Sep 2023 06:00:00 -0400</pubDate><ttl> 120</ttl><item><title>更正：管理心血管疾病的心理健康和情绪方面：患者休息室的观点</title><link/>https://pubmed.ncbi.nlm.nih.gov/37742083/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20230924203716&amp;v=2.17.9.post6+86293ac<description>无摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J. 2023 Sep 22:ehad589.doi: 10.1093/eurheartj/ehad589. 印刷前在线。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37742083/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230924203716&v=2.17.9.post6+86293ac">37742083</a> | DOI： <a href=https://doi.org/10.1093/eurheartj/ehad589>10.1093/eurheartj/ehad589</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37742083</guid><pubDate> Sun, 24 Sep 2023 06:00:00 -0400</pubDate><dc:date> 2023-09-24</dc:date><dc:source>欧洲心脏杂志</dc:source><dc:title>更正：管理心血管疾病的心理健康和情绪方面：患者休息室的观点</dc:title><dc:identifier>下午：37742083</dc:identifier><dc:identifier> doi:10.1093/eurheartj/ehad589</dc:identifier></item><item><title>淀粉体沉降使 LAZY 重新极化以实现植物的重力感应</title><link/>https://pubmed.ncbi.nlm.nih.gov/37741279/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20230924203716&amp;v=2.17.9.post6+86293ac<description>重力控制植物的定向生长，一个多世纪前提出的经典淀粉平衡石假说假设特殊细胞中的淀粉体沉积启动重力感应，但分子机制仍未表征。LAZY 蛋白被称为向地性的关键调节因子，并且懒惰突变体表现出显着的向重力缺陷。在这里，我们报告说，通过重新定向来刺激重力会触发丝裂原激活蛋白激酶 (MAPK)... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Cell</b> . 2023 年 9 月 20 日：S0092-8674(23)01035-8. doi: 10.1016/j.cell.2023.09.014. 印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">重力控制植物的定向生长，一个多世纪前提出的经典淀粉平衡石假说假设特殊细胞中的淀粉体沉积启动重力感应，但分子机制仍未表征。LAZY 蛋白被称为向地性的关键调节因子，并且懒惰突变体表现出显着的向重力缺陷。在这里，我们报告说，通过重新定向的重力刺激会触发丝裂原激活蛋白激酶（MAPK）信号介导的拟南芥LAZY蛋白在根小柱细胞中基底极化的磷酸化。LAZY的磷酸化增加了其与多个易位子的相互作用造粉体表面叶绿体 (TOC) 蛋白的外膜，促进 LAZY 蛋白在造粉体上的富集。造粉体沉降随后引导 LAZY 重新定位到小柱细胞质膜的新下侧，其中 LAZY 诱导不对称的生长素分布，并且根差异生长. 总之，这项研究为淀粉平衡石假说提供了分子解释：细胞器运动触发分子极性形成。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37741279/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230924203716&v=2.17.9.post6+86293ac">37741279</a> | DOI： <a href=https://doi.org/10.1016/j.cell.2023.09.014>10.1016/j.cell.2023.09.014</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37741279</guid><pubDate> Sat, 23 Sep 2023 06:00:00 -0400</pubDate><dc:creator>陈家跃</dc:creator><dc:creator>于仁波</dc:creator><dc:creator>李娜</dc:creator><dc:creator>邓兆国</dc:creator><dc:creator>张欣欣</dc:creator><dc:creator>赵雅然</dc:creator><dc:creator>成府区</dc:creator><dc:creator>袁艳芳</dc:creator><dc:creator>潘哲贤</dc:creator><dc:creator>周阳阳</dc:creator><dc:creator>李昆仑</dc:creator><dc:creator>王家俊</dc:creator><dc:creator>陈志仁</dc:creator><dc:creator>王晓仪</dc:creator><dc:creator>王晓莲</dc:creator><dc:creator>何树楠</dc:creator><dc:creator>董娟</dc:creator><dc:creator>邓兴旺</dc:creator><dc:creator>陈浩东</dc:creator><dc:date>2023-09-23</dc:date><dc:source>细胞</dc:source><dc:title>淀粉体沉降使 LAZY 重新极化以实现植物的重力感应</dc:title><dc:identifier>下午：37741279</dc:identifier><dc:identifier> doi:10.1016/j.cell.2023.09.014</dc:identifier></item><item><title> Bentall 手术后出现“瓣周漏”，但不是瓣周漏</title><link/>https://pubmed.ncbi.nlm.nih.gov/37740945/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20230924203716&amp;v=2.17.9.post6+86293ac<description>无摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J. 2023 Sep 23:ehad607.doi: 10.1093/eurheartj/ehad607. 印刷前在线。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37740945/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230924203716&v=2.17.9.post6+86293ac">37740945</a> | DOI： <a href=https://doi.org/10.1093/eurheartj/ehad607>10.1093/eurheartj/ehad607</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37740945</guid><pubDate> Sat, 23 Sep 2023 06:00:00 -0400</pubDate><dc:creator>穆罕默德·伊德里斯</dc:creator><dc:creator>阿伦·库马尔</dc:creator><dc:creator>巴什韦拉尤丹</dc:creator><dc:date>2023-09-23</dc:date><dc:source>欧洲心脏杂志</dc:source><dc:title>Bentall 手术后出现“瓣周漏”，但不是瓣周漏</dc:title><dc:identifier>下午：37740945</dc:identifier><dc:identifier> doi:10.1093/eurheartj/ehad607</dc:identifier></item><item><title>颈椎病诱发的长QT综合征</title><link/>https://pubmed.ncbi.nlm.nih.gov/37740436/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20230924203716&amp;v=2.17.9.post6+86293ac<description>无摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J. 2023 Sep 22:ehad608.doi: 10.1093/eurheartj/ehad608. 印刷前在线。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37740436/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230924203716&v=2.17.9.post6+86293ac">37740436</a> | DOI： <a href=https://doi.org/10.1093/eurheartj/ehad608>10.1093/eurheartj/ehad608</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37740436</guid><pubDate> Sat, 23 Sep 2023 06:00:00 -0400</pubDate><dc:creator>恩力</dc:creator><dc:creator>严超武</dc:creator><dc:creator>杨晓宇</dc:creator><dc:date>2023-09-23</dc:date><dc:source>欧洲心脏杂志</dc:source><dc:title>颈椎病诱发的长QT综合征</dc:title><dc:identifier>下午：37740436</dc:identifier><dc:identifier> doi:10.1093/eurheartj/ehad608</dc:identifier></item><item><title>心包切开术治疗射血分数保留的心力衰竭：第一项临床研究</title><link/>https://pubmed.ncbi.nlm.nih.gov/37740430/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20230924203716&amp;v=2.17.9.post6+86293ac<description>无摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J. 2023 Sep 22:ehad620.doi: 10.1093/eurheartj/ehad620. 印刷前在线。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37740430/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230924203716&v=2.17.9.post6+86293ac">37740430</a> | DOI： <a href=https://doi.org/10.1093/eurheartj/ehad620>10.1093/eurheartj/ehad620</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37740430</guid><pubDate> Sat, 23 Sep 2023 06:00:00 -0400</pubDate><dc:creator>巴里·博洛格</dc:creator><dc:creator>哈泽尔诉沙夫</dc:creator><dc:creator>塞缪尔·J·阿瑟瓦瑟姆</dc:creator><dc:creator>凯特琳·E·科普</dc:creator><dc:creator>威廉·J·莫尔曼</dc:creator><dc:creator>菲利普·G·罗斯</dc:creator><dc:date>2023-09-23</dc:date><dc:source>欧洲心脏杂志</dc:source><dc:title>心包切开术治疗射血分数保留的心力衰竭：第一项临床研究</dc:title><dc:identifier>下午：37740430</dc:identifier><dc:identifier> doi:10.1093/eurheartj/ehad620</dc:identifier></item><item><title> SARS-CoV-2 变体进化出收敛策略来重塑宿主反应</title><link/>https://pubmed.ncbi.nlm.nih.gov/37738970/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20230924203716&amp;v=2.17.9.post6+86293ac<description> SARS-CoV-2 关注变体 (VOC) 在 COVID-19 大流行期间出现。在这里，我们使用无偏系统方法来研究驱动 VOC 进化的宿主选择力。我们发现 VOC 进化出收敛策略，通过调节来重塑宿主病毒 RNA 和蛋白质水平，改变病毒和宿主蛋白质磷酸化，并重新连接病毒-宿主蛋白质-蛋白质相互作用。综合计算分析表明，尽管 Alpha、Beta、Gamma 和 Delta 最终... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Cell</b> . 2023 年 9 月 19 日：S0092-8674(23)00915-7. doi: 10.1016/j.cell.2023.08.026. 印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> SARS-CoV-2 关注变体 (VOC) 在 COVID-19 大流行期间出现。在这里，我们使用无偏系统方法来研究驱动 VOC 进化的宿主选择力。我们发现 VOC 进化出收敛策略，通过调节来重塑宿主病毒 RNA 和蛋白质水平，改变病毒和宿主蛋白质磷酸化，并重新连接病毒-宿主蛋白质-蛋白质相互作用。综合计算分析表明，尽管 Alpha、Beta、Gamma 和 Delta 最终汇聚到抑制干扰素刺激基因 (ISG)，但 Omicron BA.1 没有。ISG 抑制与病毒先天免疫拮抗蛋白的表达相关，包括 Orf6、N 和 Orf9b，我们将其映射到特定突变。后来的 Omicron 亚变体 BA.4 和 BA.5 比它更有效地抑制先天免疫。早期亚变体 BA.1，与 Orf6 水平相关，尽管在 BA.4 中由于破坏 Orf6 与核孔相互作用的突变而被抑制。我们的研究结果表明，SARS-CoV-2 趋同进化克服了人类适应性和先天免疫障碍，奠定了基础为应对未来流行病奠定基础。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37738970/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230924203716&v=2.17.9.post6+86293ac">37738970</a> | DOI： <a href=https://doi.org/10.1016/j.cell.2023.08.026>10.1016/j.cell.2023.08.026</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37738970</guid><pubDate> Fri, 22 Sep 2023 06:00:00 -0400</pubDate><dc:creator>迈赫迪·布哈杜</dc:creator><dc:creator>安-凯瑟琳·罗伊施尔</dc:creator><dc:creator>本杰明·波拉科</dc:creator><dc:creator>露西·G·索恩</dc:creator><dc:creator>马尼沙·R·乌马迪</dc:creator><dc:creator>叶成金</dc:creator><dc:creator>罗梅尔·罗萨莱斯</dc:creator><dc:creator>阿德里安·佩林</dc:creator><dc:creator>乔蒂·巴特拉</dc:creator><dc:creator>格温多林·M·张</dc:creator><dc:creator>徐杰伟</dc:creator><dc:creator>杰克·莫恩</dc:creator><dc:creator>艾丽西亚·L·理查兹</dc:creator><dc:creator>袁州</dc:creator><dc:creator>巴维亚·哈贾伊</dc:creator><dc:creator>艾丽卡·史蒂文森</dc:creator><dc:creator>阿吉达·罗伊克</dc:creator><dc:creator>罗伯塔·拉加齐尼</dc:creator><dc:creator>马修·VX·惠兰</dc:creator><dc:creator>威廉·弗农</dc:creator><dc:creator>朱迪塔·德·洛伦佐</dc:creator><dc:creator>凡妮莎·考顿</dc:creator><dc:creator>阿卜杜拉·赛义德</dc:creator><dc:creator>艾莉森·西林</dc:creator><dc:creator>诺亚·多伊奇</dc:creator><dc:creator>丹尼尔·皮拉克</dc:creator><dc:creator>朱莉娅·道吉尔</dc:creator><dc:creator>德扬·梅斯纳</dc:creator><dc:creator>简·L·特纳</dc:creator><dc:creator>布莱恩娜·L·麦戈文</dc:creator><dc:creator>M路易斯·罗德里格斯</dc:creator><dc:creator>罗西奥·雷瓦-雷博洛</dc:creator><dc:creator>阿利斯泰尔·邓纳姆</dc:creator><dc:creator>钟晓芳</dc:creator><dc:creator>曼农·埃克哈特</dc:creator><dc:creator>安德里亚·福萨蒂</dc:creator><dc:creator>尼古拉斯·F·利奥塔</dc:creator><dc:creator>托马斯·凯勒</dc:creator><dc:creator>阿纳斯塔西娅·丘皮克</dc:creator><dc:creator>玛格达莱娜·鲁特科斯卡</dc:creator><dc:creator>伊格纳西奥·梅纳</dc:creator><dc:creator>萨达夫·阿斯拉姆</dc:creator><dc:creator>艾莉莎·霍弗特</dc:creator><dc:creator>海伦·福萨德</dc:creator><dc:creator>查尔斯·奥钦·奥尔瓦尔</dc:creator><dc:creator>黄伟庆</dc:creator><dc:creator>托马斯·兹瓦卡</dc:creator><dc:creator>约翰·范</dc:creator><dc:creator>莫莉·莱昂斯</dc:creator><dc:creator>劳拉·多诺霍</dc:creator><dc:creator>阿莉莎·格里芬</dc:creator><dc:creator>丽贝卡·纽金特</dc:creator><dc:creator>凯文·霍尔登</dc:creator><dc:creator>罗伯特·迪恩斯</dc:creator><dc:creator>巴勃罗·阿维莱斯</dc:creator><dc:creator>何塞·洛佩斯·马丁</dc:creator><dc:creator>何塞·M·希梅诺</dc:creator><dc:creator>克尔斯滕·奥伯尼尔</dc:creator><dc:creator>杰奎琳·M·法比尤斯</dc:creator><dc:creator>玛格丽特·苏切雷</dc:creator><dc:creator>露丝·胡滕海恩</dc:creator><dc:creator>欧文·荣格莱斯</dc:creator><dc:creator>马诺利斯·凯利斯</dc:creator><dc:creator>伊格纳西娅·埃切维里亚</dc:creator><dc:creator>克里门特·维尔巴</dc:creator><dc:creator>保拉·邦凡蒂</dc:creator><dc:creator>佩德罗·贝尔特劳</dc:creator><dc:creator>罗德·夏兰</dc:creator><dc:creator>詹妮弗·杜德纳</dc:creator><dc:creator>路易斯·马丁内斯-索布里多</dc:creator><dc:creator>阿文德·H·帕特尔</dc:creator><dc:creator>马西莫·帕尔马里尼</dc:creator><dc:creator>丽莎·米奥林</dc:creator><dc:creator>克里斯·怀特</dc:creator><dc:creator>丹妮尔·L·斯瓦尼</dc:creator><dc:creator>阿道夫·加西亚·萨斯特雷</dc:creator><dc:creator>克莱尔乔利</dc:creator><dc:creator>洛雷娜·祖利亚尼-阿尔瓦雷斯</dc:creator><dc:creator>格雷格·J·塔尔斯</dc:creator><dc:creator>内万·J·克罗根</dc:creator><dc:date>2023-09-22</dc:date><dc:source>细胞</dc:source><dc:title>SARS-CoV-2 变体进化出收敛策略来重塑宿主反应</dc:title><dc:identifier>下午:37738970</dc:identifier><dc:identifier> doi:10.1016/j.cell.2023.08.026</dc:identifier></item><item><title>我们能否显着提高对复发性冠状动脉疾病事件的预测？</title><link/> https://pubmed.ncbi.nlm.nih.gov/37738645/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20230924203716&amp;v=2.17.9.post6+86293ac<description>无摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> 《欧洲心脏杂志》2023 年 9 月 21 日；44(36):3466-3468.doi: 10.1093/eurheartj/ehad464。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37738645/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230924203716&v=2.17.9.post6+86293ac">37738645</a> | DOI： <a href=https://doi.org/10.1093/eurheartj/ehad464>10.1093/eurheartj/ehad464</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37738645</guid><pubDate> Fri, 22 Sep 2023 06:00:00 -0400</pubDate><dc:creator>威廉·温特劳布</dc:creator><dc:creator>威廉·博登</dc:creator><dc:date>2023-09-22</dc:date><dc:source>欧洲心脏杂志</dc:source><dc:title>我们能否显着提高对复发性冠状动脉疾病事件的预测？</dc:title><dc:identifier>下午：37738645</dc:identifier><dc:identifier> doi:10.1093/eurheartj/ehad464</dc:identifier></item><item><title>预测的挑战和机遇：关注缺血性心脏病和心房颤动</title><link/>https://pubmed.ncbi.nlm.nih.gov/37738644/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20230924203716&amp;v=2.17.9.post6+86293ac<description>无摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> 《欧洲心脏杂志》2023 年 9 月 21 日；44(36):3391-3394.doi: 10.1093/eurheartj/ehad614。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37738644/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230924203716&v=2.17.9.post6+86293ac">37738644</a> | DOI： <a href=https://doi.org/10.1093/eurheartj/ehad614>10.1093/eurheartj/ehad614</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37738644</guid><pubDate> Fri, 22 Sep 2023 06:00:00 -0400</pubDate><dc:creator>菲利波·克雷亚</dc:creator><dc:date>2023-09-22</dc:date><dc:source>欧洲心脏杂志</dc:source><dc:title>预测的挑战和机遇：关注缺血性心脏病和心房颤动</dc:title><dc:identifier>下午:37738644</dc:identifier><dc:identifier> doi:10.1093/eurheartj/ehad614</dc:identifier></item><item><title>更正：2023 ESC 心内膜炎管理指南：由欧洲心脏病学会 (ESC) 心内膜炎管理工作组制定，并得到欧洲心胸外科协会 (EACTS) 和欧洲核协会认可医学（EANM）</title><link/> https://pubmed.ncbi.nlm.nih.gov/37738322/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20230924203716&amp;v=2.17.9.post6+86293ac<description>无摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J. 2023 Sep 20:ehad625.doi: 10.1093/eurheartj/ehad625. 印刷前在线。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37738322/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230924203716&v=2.17.9.post6+86293ac">37738322</a> | DOI： <a href=https://doi.org/10.1093/eurheartj/ehad625>10.1093/eurheartj/ehad625</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37738322</guid><pubDate> Fri, 22 Sep 2023 06:00:00 -0400</pubDate><dc:date> 2023-09-22</dc:date><dc:source>欧洲心脏杂志</dc:source><dc:title>更正：2023 ESC 心内膜炎管理指南：由欧洲心脏病学会 (ESC) 心内膜炎管理工作组制定，并得到欧洲心胸外科协会 (EACTS) 和欧洲核协会认可医学（EANM）</dc:title><dc:identifier>下午:37738322</dc:identifier><dc:identifier> doi:10.1093/eurheartj/ehad625</dc:identifier></item><item><title>出生体重影响心脏结构、功能和疾病风险：因果关系的证据</title><link/>https://pubmed.ncbi.nlm.nih.gov/37738114/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20230924203716&amp;v=2.17.9.post6+86293ac<description>结论：这项研究的结果支持低出生体重与心血管疾病的因果关系，即使考虑了宫内环境的影响。这表明低出生体重的个体可能受益于有针对性的早期心血管疾病预防策略，独立的这是否与妊娠期间不利的宫内环境有关。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J. 2023 Sep 20:ehad631.doi: 10.1093/eurheartj/ehad631. 印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景和目的：低出生体重是一种常见的妊娠并发症，与晚年罹患心脏代谢疾病的较高风险相关。之前探索此问题的孟德尔随机化 (MR) 研究并未区分直接影响出生体重的变异的机制贡献通过胎儿基因组（直接胎儿影响），与通过引起不利的子宫内环境间接影响出生体重的变异（间接母体影响）。在这项研究中，MR 用于评估独立于子宫内影响的出生体重是否与心血管疾病风险以及不良心脏结构和功能的测量。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：从全基因组关联研究总体出生体重的汇总统计数据中提取不相关（r2 &lt; .001）、全基因组显着性（P &lt; 5 × 10-8）单核苷酸多态性，并且仅在分离直接胎儿影响后进行。方差加权 MR 用于分析心房颤动、冠状动脉疾病、心力衰竭、缺血性中风以及 16 项心脏结构和功能测量的结果。通过 Benjamini-Hochberg 校正进行多重比较。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：较低的遗传预测出生体重（仅隔离对胎儿的直接影响）与冠状动脉疾病风险增加（比值比 1.21，95% 置信区间 1.06-1.37；P = 0.031）、较小的心室容积和较低的冠状动脉疾病风险相关。每搏输出量，但收缩力较高。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：这项研究的结果支持低出生体重与心血管疾病的因果关系，即使考虑了宫内环境的影响。这表明低出生体重的个体可能受益于有针对性的早期心血管疾病预防策略，独立的这是否与妊娠期间不利的宫内环境有关。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37738114/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230924203716&v=2.17.9.post6+86293ac">37738114</a> | DOI： <a href=https://doi.org/10.1093/eurheartj/ehad631>10.1093/eurheartj/ehad631</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37738114</guid><pubDate> Fri, 22 Sep 2023 06:00:00 -0400</pubDate><dc:creator>马达莱娜·阿迪西诺</dc:creator><dc:creator>亚历克·P·莫利</dc:creator><dc:creator>埃里克·AW·斯洛布</dc:creator><dc:creator>阿特·舒尔曼斯</dc:creator><dc:creator>比拉尔·雷耶斯</dc:creator><dc:creator>扎赫拉·莱西·埃斯塔布拉</dc:creator><dc:creator>安东尼奥·德·马尔旺</dc:creator><dc:creator>史蒂芬·伯吉斯</dc:creator><dc:creator>托莫德·罗涅</dc:creator><dc:creator>迈克尔·C·霍尼伯格</dc:creator><dc:creator>吴富祥</dc:creator><dc:date>2023-09-22</dc:date><dc:source>欧洲心脏杂志</dc:source><dc:title>出生体重影响心脏结构、功能和疾病风险：因果关系的证据</dc:title><dc:identifier>下午：37738114</dc:identifier><dc:identifier> doi:10.1093/eurheartj/ehad631</dc:identifier></item><item><title> PPP1R12C 促进心房颤动中的心房收缩力减退</title><link/>https://pubmed.ncbi.nlm.nih.gov/37737016/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20230924203716&amp;v=2.17.9.post6+86293ac<description>结论：与对照组相比，AF 患者的 PPP1R12C 蛋白水平升高。小鼠中 PPP1R12C 过表达增加了 PP1c 靶向 MLC2a 并导致 MLC2a 去磷酸化，从而降低心房收缩力并增加 AF 诱导性。这些发现表明 PP1 对 MLC2a 肌节功能的调节是AF 心房收缩力的关键决定因素。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Circ Res. 2023 年 9 月 22 日。doi：10.1161/CIRCRESAHA.123.322516。印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：心房颤动 (AF) - 最常见的持续性心律失常 - 使血栓栓塞性中风风险增加 5 倍。虽然心房收缩力不足会导致 AF 中风风险，但降低肌丝收缩功能的分子机制仍不清楚。我们测试了以下假设：表达增加PPP1R12C（蛋白磷酸酶 1 调节亚基 12C）——靶向 MLC2a（心房肌球蛋白轻链 2）的 PP1（蛋白磷酸酶 1）调节亚基——导致 MLC2a 磷酸化不足，导致心房收缩力减退。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：从 AF 患者与窦性心律对照患者中分离右心耳组织。进行蛋白质印迹、免疫共沉淀和磷酸化研究，以检查 PP1c（PP1 催化亚基）-PPP1R12C 相互作用如何导致 MLC2a 去磷酸化。药理学体外研究在心房 HL-1 细胞中进行 MRCK（肌强直性营养不良激酶相关的 Cdc42 结合激酶）抑制剂 (BDP5290) 来评估 PP1 全酶对 MLC2a 的活性。在小鼠中进行心脏特异性慢病毒 PPP1R12C 过表达，以评估伴随心房细胞缩短的心房重塑测定、超声心动图和电生理学研究的 AF 诱导性。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：在人类 AF 患者中，PPP1R12C 表达比窦性心律对照增加 2 倍（ <i>P</i> =2.0×10 <sup>-</sup> <sup>2</sup> ；每组 n=12 和 12），MLC2a 磷酸化减少 >; 40%（ <i>P</i> =1.4× 10 <sup>-</sup> <sup>6</sup> ；每组 n=12 和 12）。AF 中 PPP1R12C-PP1c 结合和 PPP1R12C-MLC2a 结合显着增加（ <i>P</i>分别 =2.9×10 <sup>-2</sup>和 6.7×10 <sup>-3</sup> ；n=8 和 8使用抑制 T560-PPP1R12C 磷酸化的药物 BDP5290 的体外研究表明 PPP1R12C 与 PP1c 和 MLC2a 的结合增加以及 MLC2a 的去磷酸化。用慢病毒 PPP1R12C 载体治疗的小鼠与对照组相比左心房大小增加了 150% ( <i>P</i> =5.0×10 <sup>-</sup> <sup>6</sup> ; n=12, 8, 和 12)，心房应变和心房射血分数降低。慢病毒 PPP1R12C 载体治疗的小鼠起搏诱发的 AF 显着高于对照组 ( <i>P</i> =1.8×分别为10 <sup>-2</sup>和4.1×10 <sup>-2</sup> ；n=6、6和5）。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：与对照组相比，AF 患者的 PPP1R12C 蛋白水平升高。小鼠中 PPP1R12C 过表达增加了 PP1c 靶向 MLC2a 并导致 MLC2a 去磷酸化，从而降低心房收缩力并增加 AF 诱导性。这些发现表明 PP1 对 MLC2a 肌节功能的调节是AF 心房收缩力的关键决定因素。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37737016/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230924203716&v=2.17.9.post6+86293ac">37737016</a> | DOI： <a href=https://doi.org/10.1161/CIRCRESAHA.123.322516>10.1161/CIRCRESAHA.123.322516</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37737016</guid><pubDate> Fri, 22 Sep 2023 06:00:00 -0400</pubDate><dc:creator>斯里坎特·佩里克</dc:creator><dc:creator>弗朗西斯科·J·冈萨雷斯-冈萨雷斯</dc:creator><dc:creator>伊萨姆·阿布·塔哈</dc:creator><dc:creator>弗雷德里克·W·达门</dc:creator><dc:creator>劳林·M·汉夫特</dc:creator><dc:creator>肯·利扎马</dc:creator><dc:creator>安娜希塔·阿布纳比</dc:creator><dc:creator>安德里埃尔·E·卡波特</dc:creator><dc:creator>尤里亚娜·阿吉拉尔-桑切斯</dc:creator><dc:creator>本杰明·莱文</dc:creator><dc:creator>韩振波</dc:creator><dc:creator>阿尔温德·斯里达尔</dc:creator><dc:creator>雅各布·格兰德</dc:creator><dc:creator>乔迪·马丁</dc:creator><dc:creator>约瑟夫·G·阿卡尔</dc:creator><dc:creator>查德·M·沃伦</dc:creator><dc:creator>R约翰·索拉罗</dc:creator><dc:creator>王相庆</dc:creator><dc:creator>达乌德·达巴尔</dc:creator><dc:creator>克里·麦克唐纳</dc:creator><dc:creator>克雷格·格尔根</dc:creator><dc:creator>贝亚塔·M·沃尔斯卡</dc:creator><dc:creator>多布罗米尔·多布雷夫</dc:creator><dc:creator>桑德尔·HT·维伦斯</dc:creator><dc:creator>马克·D·麦考利</dc:creator><dc:date>2023-09-22</dc:date><dc:source>流通研究</dc:source><dc:title>PPP1R12C 促进心房颤动中的心房收缩力减退</dc:title><dc:identifier>下午：37737016</dc:identifier><dc:identifier> doi:10.1161/CIRCRESAHA.123.322516</dc:identifier></item><item><title>在 32 个低收入和中等收入国家实施全球心脏病高血压控制计划：JACC International</title><link/> https://pubmed.ncbi.nlm.nih.gov/37734459/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20230924203716&amp;v=2.17.9.post6+86293ac<description> 2017 年，世界卫生组织 (WHO) 和 Resolve to Save Lives 与各国政府和其他利益相关者合作，在 32 个低收入和中等收入国家设计、测试和扩大 WHO HEARTS 高血压服务包。绩效指标包括入组患者人数、接受治疗且血压得到控制的患者人数、错过预定随访的人数以及失访人数。到 2022 年，HEARTS 高血压控制计划... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> J Am Coll Cardiol。2023 年 9 月 19 日：S0735-1097(23)06633-0。doi：10.1016/j.jacc.2023.08.043。印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> 2017 年，世界卫生组织 (WHO) 和 Resolve to Save Lives 与各国政府和其他利益相关者合作，在 32 个低收入和中等收入国家设计、测试和扩大 WHO HEARTS 高血压服务包。绩效指标包括入组患者人数、接受治疗且血压得到控制的患者人数、错过预定随访的人数以及失访人数。到 2022 年，HEARTS 高血压控制计划已在 165,000 个初级保健机构中治疗了 1,220 万名患者高血压控制率为 38%（中位数 48%；范围 5%-86%）。在使用相同数字健康信息系统的 4 HEARTS 国家中，基于设施的控制在 48 个月内从基线时的 18% 提高到 46%。人口水平，基于人群的高血压控制中位数估计为所有高血压患者的 11.0%（范围 2.0%-34.7%）。全球心脏实施 WHO HEARTS 的经验证明了在低收入和中等收入国家初级保健机构中控制高血压的可行性。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37734459/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230924203716&v=2.17.9.post6+86293ac">37734459</a> | DOI： <a href=https://doi.org/10.1016/j.jacc.2023.08.043>10.1016/j.jacc.2023.08.043</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37734459</guid><pubDate> Thu, 21 Sep 2023 06:00:00 -0400</pubDate><dc:creator>安德鲁·E·莫兰</dc:creator><dc:creator>丽娜·古普塔</dc:creator><dc:creator>全球之心倡议合作者</dc:creator><dc:date>2023-09-21</dc:date><dc:source>美国心脏病学会杂志</dc:source><dc:title>在 32 个低收入和中等收入国家实施全球心脏病高血压控制计划：JACC International</dc:title><dc:identifier>下午:37734459</dc:identifier><dc:identifier> doi:10.1016/j.jacc.2023.08.043</dc:identifier></item><item><title> Mpox 感染可防止恒河猴再次受到攻击</title><link/>https://pubmed.ncbi.nlm.nih.gov/37734373/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20230924203716&amp;v=2.17.9.post6+86293ac<description> 2022-2023 年的 MPOX 爆发涉及男男性行为者中的全球快速传播。我们通过静脉内、皮内和直肠内途径感染了 18 只恒河猴，并在所有三种感染途径后观察到了强烈的抗体和 T 细胞反应。静脉内和皮内感染后观察到许多皮肤损伤和高血浆病毒载量。皮肤损伤在感染后第 10 天达到顶峰，并在感染后第 28 天消退。第 28 天，我们重新挑战所有... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Cell</b> . 2023 年 9 月 13 日：S0092-8674(23)00911-X. doi: 10.1016/j.cell.2023.08.023. 印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> 2022-2023 年的 MPOX 爆发涉及男男性行为者中的全球快速传播。我们通过静脉内、皮内和直肠内途径感染了 18 只恒河猴，并在所有三种感染途径后观察到了强烈的抗体和 T 细胞反应。静脉内和皮内感染后观察到许多皮肤损伤和高血浆病毒载量。皮肤损伤在感染后第 10 天达到顶峰，并在感染后第 28 天消退。第 28 天，我们用 MPOX 重新攻击所有恢复期动物和 3 只初始动物。所有恢复期动物受到保护免受再次攻击。转录组学研究表明，攻击后先天反应和炎症反应上调，胶原形成和细胞外基质组织下调，以及再次攻击后 T 细胞和浆细胞反应快速激活。这些数据表明关键机制深入了解 MPOX 发病机制和免疫。这种猕猴模型应该有助于评估 MPOX 疫苗和治疗方法。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37734373/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230924203716&v=2.17.9.post6+86293ac">37734373</a> | DOI： <a href=https://doi.org/10.1016/j.cell.2023.08.023>10.1016/j.cell.2023.08.023</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37734373</guid><pubDate> Thu, 21 Sep 2023 06:00:00 -0400</pubDate><dc:creator>马利卡援助</dc:creator><dc:creator>米凯拉·夏卡</dc:creator><dc:creator>凯瑟琳·麦克马汉</dc:creator><dc:creator>大卫·霍普</dc:creator><dc:creator>刘金艳</dc:creator><dc:creator>凯瑟琳·雅各布·多兰</dc:creator><dc:creator>奥利维亚·鲍尔斯</dc:creator><dc:creator>朱莉娅·巴雷特</dc:creator><dc:creator>吴欣迪</dc:creator><dc:creator>奥黛丽·穆托尼</dc:creator><dc:creator>泰蒂亚娜·穆尔扎</dc:creator><dc:creator>汉娜·里克特</dc:creator><dc:creator>贾森·贝拉斯科</dc:creator><dc:creator>爱丽丝·张</dc:creator><dc:creator>莫娜·布尔西夸</dc:creator><dc:creator>安东尼·库克</dc:creator><dc:creator>塔季扬娜·奥列科夫</dc:creator><dc:creator>梅丽莎·汉密尔顿</dc:creator><dc:creator>洛朗·佩森特</dc:creator><dc:creator>阿莱娜·瑞安</dc:creator><dc:creator>塔米·海耶斯</dc:creator><dc:creator>阿曼达·J·马蒂诺特</dc:creator><dc:creator>迈克尔·西曼</dc:creator><dc:creator>马克·G·刘易斯</dc:creator><dc:creator>汉娜·安徒生</dc:creator><dc:creator>丹·巴鲁克</dc:creator><dc:date>2023-09-21</dc:date><dc:source>细胞</dc:source><dc:title>Mpox 感染可防止恒河猴再次受到攻击</dc:title><dc:identifier>下午:37734373</dc:identifier><dc:identifier> doi:10.1016/j.cell.2023.08.023</dc:identifier></item><item><title>宿主特征影响野生小型哺乳动物的病毒组组成和病毒传播</title><link/>https://pubmed.ncbi.nlm.nih.gov/37734372/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20230924203716&amp;v=2.17.9.post6+86293ac<description>蝙蝠、啮齿动物和鼩鼱是人类传染病最重要的动物来源，然而，它们之间病毒的进化和传播在很大程度上仍未被探索。通过对2,443个野生蝙蝠、啮齿动物的内脏和粪便样本进行宏转录组测序，和来自中国四个栖息地的鼩鼱样本，我们鉴定出 669 种病毒，其中包括 534 种新病毒，从而大大扩展了哺乳动物病毒组。我们的分析揭示了高水平的系统发育...... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Cell</b> . 2023 年 9 月 14 日：S0092-8674(23)00916-9. doi: 10.1016/j.cell.2023.08.029. 印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">蝙蝠、啮齿动物和鼩鼱是人类传染病最重要的动物来源，然而，它们之间病毒的进化和传播在很大程度上仍未被探索。通过对2,443个野生蝙蝠、啮齿动物的内脏和粪便样本进行宏转录组测序，我们从中国四个栖息地的样本和鼩鼱样本中鉴定出 669 种病毒，其中包括 534 种新病毒，从而极大地扩展了哺乳动物病毒组。我们的分析揭示了高水平的系统发育多样性，确定了跨物种病毒传播事件，阐明了病毒起源，并确定了哺乳动物宿主中的无脊椎动物病毒。宿主顺序和样本大小是影响病毒组组成和病毒溢出模式的最重要因素。鼩鼱携带的病毒丰富度很高，包括许多与多器官分布的无脊椎动物相关病毒，而啮齿类动物则携带病毒更强的宿主跳跃能力。这些数据突显了当地栖息地中哺乳动物病毒的显着多样性以及它们在新宿主中出现的能力。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37734372/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230924203716&v=2.17.9.post6+86293ac">37734372</a> | DOI： <a href=https://doi.org/10.1016/j.cell.2023.08.029>10.1016/j.cell.2023.08.029</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37734372</guid><pubDate> Thu, 21 Sep 2023 06:00:00 -0400</pubDate><dc:creator>陈艳梅</dc:creator><dc:creator>胡树建</dc:creator><dc:creator>林贤丹</dc:creator><dc:creator>田俊华</dc:creator><dc:creator>吕家新</dc:creator><dc:creator>王妙若</dc:creator><dc:creator>罗秀琪</dc:creator><dc:creator>裴媛媛</dc:creator><dc:creator>胡瑞雪</dc:creator><dc:creator>宋志刚</dc:creator><dc:creator>爱德华·C·霍姆斯</dc:creator><dc:creator>张永珍</dc:creator><dc:date>2023-09-21</dc:date><dc:source>细胞</dc:source><dc:title>宿主特征影响野生小型哺乳动物的病毒组组成和病毒传播</dc:title><dc:identifier>下午:37734372</dc:identifier><dc:identifier> doi:10.1016/j.cell.2023.08.029</dc:identifier></item><item><title>人类诱导多能干细胞来源的心肌细胞和内皮细胞的联合治疗使小鼠和非人类灵长类动物的梗塞心脏再生</title><link/>https://pubmed.ncbi.nlm.nih.gov/37732466/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20230924203716&amp;v=2.17.9.post6+86293ac<description>结论：这些结果证明了将 iPSC 衍生的 EC 和 CM 相结合用于治疗心肌梗死后心脏的协同效应，为临床转化提供了一种有前景的策略。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>。2023 年 9 月 21 日。doi：10.1161/CIRCULATIONAHA.122.061736。印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：将人诱导多能干细胞（hiPSC）来源的心肌细胞（CM）进行细胞移植后，可以实现哺乳动物心脏的再肌化，但在临床实践中仍存在一些障碍。血管形成，致命性心律失常发生的可能性与未成熟 CM 的胎儿细胞样性质有关。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：我们从 3 个独立供体中生成了 3 系 hiPSC 衍生内皮细胞 (EC) 和 hiPSC-CM，并在与 EC 共培养中测试了 hiPSC-CM 肌节长度、间隙连接蛋白和钙处理能力。 hiPSC-EC 和 hiPSC-CM 联合移植对心肌梗死 NOD-SCID 小鼠（n≥4）的治疗效果。通过超声心动图评估心功能，同时使用 3 导联心电图记录心律失常事件。我们进一步使用健康非-人类灵长类动物（n = 4）注射细胞，通过组织学分析研究移植的 hiPSC-CM 的细胞植入、成熟和整合，单独或与 hiPSC-EC 一起。最后，我们测试了缺血再灌注损伤中的细胞疗法在非人类灵长类动物中（EC+CM、CM 和对照分别为 4、3 和 4）。通过超声心动图和心脏 MRI 评估心脏功能，而通过遥测心电图记录仪监测心律失常事件。细胞植入，还研究了血管生成和人体移植物的宿主-移植物整合。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：我们证明人 iPSC-EC 在体外和体内均可促进 hiPSC-CM 的成熟和功能。当与 EC 共培养时，CM 在细胞结构和功能方面表现出更成熟的表型。在小鼠模型中，共移植增强了 EC-伴随移植物血管化，促进梗死区CM的成熟，改善心肌梗死后的心功能。此外，在非人灵长类动物中，EC和CM的移植显着增强了移植物的大小和血管系统，改善了缺血再灌注后的心功能。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：这些结果证明了将 iPSC 衍生的 EC 和 CM 相结合用于治疗心肌梗死后心脏的协同效应，为临床转化提供了一种有前景的策略。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37732466/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230924203716&v=2.17.9.post6+86293ac">37732466</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.122.061736>10.1161 / CIRCULATIONAHA.122.061736</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37732466</guid><pubDate> Thu, 21 Sep 2023 06:00:00 -0400</pubDate><dc:creator>郑育哲</dc:creator><dc:creator>谢家文</dc:creator><dc:creator>林珍菊</dc:creator><dc:creator>张敏迪</dc:creator><dc:creator>黄静英</dc:creator><dc:creator>莱利·庞特尼</dc:creator><dc:creator>艾米吴梅</dc:creator><dc:creator>丁建宇</dc:creator><dc:creator>郑达连 陈先生</dc:creator><dc:creator>马丁·W·尼科尔森</dc:creator><dc:creator>林宝如</dc:creator><dc:creator>陈鸿志</dc:creator><dc:creator>吉娜·C·金</dc:creator><dc:creator>张建华</dc:creator><dc:creator>詹妮弗·库南</dc:creator><dc:creator>普加巴苏</dc:creator><dc:creator>希瑟·西蒙斯</dc:creator><dc:creator>刘彦文</dc:creator><dc:creator>蒂莫西·黑客</dc:creator><dc:creator>蒂莫西·坎普</dc:creator><dc:creator>谢长荣</dc:creator><dc:date>2023-09-21</dc:date><dc:source>循环</dc:source><dc:title>人类诱导多能干细胞来源的心肌细胞和内皮细胞的联合治疗使小鼠和非人类灵长类动物的梗塞心脏再生</dc:title><dc:identifier>下午：37732466</dc:identifier><dc:identifier> doi:10.1161/循环AHA.122.061736</dc:identifier></item><item><title> LAAOS III 中口服抗凝药物的使用和左心耳封堵术</title><link/>https://pubmed.ncbi.nlm.nih.gov/37732457/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20230924203716&amp;v=2.17.9.post6+86293ac<description>结论：无论患者是否接受 OAC，左心耳封堵术的益处都是一致的。左心耳封堵术可以减少患者的血栓栓塞，而与是否使用 OAC 无关。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>。2023 年 9 月 21 日。doi：10.1161/CIRCULATIONAHA.122.060315。印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：LAAOS III（左心耳封堵研究 III）表明，左心耳 (LAA) 封堵会增加接受心脏手术的心房颤动患者发生缺血性卒中或全身性栓塞的风险。本文根据左心耳 (LAA) 封堵对减少卒中的影响进行了研究。口服抗凝剂（OAC）使用的变化。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> METHODS: Information regarding OAC use was collected at every follow-up visit. Adjusted proportional hazards modeling, including using landmarks of hospital discharge, 1 and 2 years after randomization, evaluated the effect of LAA occlusion on the risk of ischemic stroke or systemic embolism, according to OAC use. Adjusted proportional hazard modeling, with OAC use as a time-dependent covariate, was also performed to assess the effect of LAA occlusion, according to OAC use throughout the study. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> RESULTS: At hospital discharge, 3027 patients (63.5%) were receiving a vitamin K antagonist, and 879 (18.5%) were receiving a non-vitamin K antagonist oral anticoagulant (direct OAC), with no difference in OAC use between treatment arms. There were 2887 (60.5%) patients who received OACs at all follow-up visits, 1401 (29.4%) who received OAC at some visits, and 472 (9.9%) who never received OACs. The effect of LAA occlusion on the risk of ischemic stroke or systemic embolism was consistent after discharge across all 3 groups: hazard ratios of 0.70 (95% CI, 0.51-0.96), 0.63 (95% CI, 0.43-0.94), and 0.76 (95% CI, 0.32-1.79), respectively. An adjusted proportional hazards model with OAC use as a time-dependent covariate showed that the reduction in stroke or systemic embolism with LAA occlusion was similar whether patients were receiving OACs or not. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> CONCLUSIONS: The benefit of LAA occlusion was consistent whether patients were receiving OACs or not. LAA occlusion provides thromboembolism reduction in patients independent of OAC use.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37732457/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230924203716&v=2.17.9.post6+86293ac">37732457</a> | DOI: <a href=https://doi.org/10.1161/CIRCULATIONAHA.122.060315>10.1161/CIRCULATIONAHA.122.060315</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37732457</guid><pubDate> Thu, 21 Sep 2023 06:00:00 -0400</pubDate><dc:creator> Stuart J Connolly</dc:creator><dc:creator> Jeff S Healey</dc:creator><dc:creator> Emilie P Belley-Cote</dc:creator><dc:creator> Kumar Balasubramanian</dc:creator><dc:creator> Domenico Paparella</dc:creator><dc:creator> Katheryn Brady</dc:creator><dc:creator> Wilko Reents</dc:creator><dc:creator> Bernhard C Danner</dc:creator><dc:creator> PJ Devereaux</dc:creator><dc:creator> Mukul Sharma</dc:creator><dc:creator> Chinthanie Ramasundarahettige</dc:creator><dc:creator> Salim Yusuf</dc:creator><dc:creator> Richard P Whitlock</dc:creator><dc:date> 2023-09-21</dc:date><dc:source> Circulation</dc:source><dc:title> Oral Anticoagulation Use and Left Atrial Appendage Occlusion in LAAOS III</dc:title><dc:identifier> pmid:37732457</dc:identifier><dc:identifier> doi:10.1161/CIRCULATIONAHA.122.060315</dc:identifier></item><item><title> Existing Nongated CT Coronary Calcium Predicts Operative Risk in Patients Undergoing Noncardiac Surgeries (ENCORES)</title><link/> https://pubmed.ncbi.nlm.nih.gov/37732454/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230924203716&amp;v=2.17.9.post6+86293ac<description> CONCLUSIONS: Prevalence and severity of coronary calcium obtained from existing nongated chest CT imaging improve preoperative clinical risk stratification before nongated surgery. </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Circulation</b> . 2023 Sep 21. doi: 10.1161/CIRCULATIONAHA.123.064398. Online ahead of print.</p><p> <b>ABSTRACT</b> </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> BACKGROUND: Preoperative cardiovascular risk stratification before noncardiac surgery is a common clinical challenge. Coronary artery calcium scores from ECG-gated chest computed tomography (CT) imaging are associated with perioperative events. At the time of preoperative evaluation, many patients will not have had ECG-gated CT imaging, but will have had nongated chest CT studies performed for a variety of noncardiac indications. We evaluated relationships between coronary calcium severity estimated from previous nongated chest CT imaging and perioperative major clinical events (MCE) after noncardiac surgery. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> METHODS: We retrospectively identified consecutive adults age ≥45 years who underwent in-hospital, major nongated surgery from 2016 to 2020 at a large academic health system composed of 4 acute care centers. All patients had nongated (contrast or noncontrast) chest CT imaging performed within 1 year before surgery. Coronary calcium in each vessel was retrospectively graded from absent to severe using a 0 to 3 scale (absent, mild, moderate, severe) by physicians blinded to clinical data. The estimated coronary calcium burden (ECCB) was computed as the sum of scores for each coronary artery (0 to 9 scale). A Revised Cardiac Risk Index was calculated for each patient. Perioperative MCE was defined as all-cause death or myocardial infarction within 30 days of surgery. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> RESULTS: A total of 2554 patients (median age, 68 years; 49.7% women; median Revised Cardiac Risk Index, 1) were included. The median time interval from nongated chest CT imaging to nongated surgery was 15 days (interquartile range, 3-106 days). The median ECCB was 1 (interquartile range, 0-3). Perioperative MCE occurred in 136 (5.2%) patients. Higher ECCB values were associated with stepwise increases in perioperative MCE (0: 2.9%, 1-2: 3.7%, 3-5: 8.0%; 6-9: 12.6%, <i>P</i> &lt;0.001). Addition of ECCB to a model with the Revised Cardiac Risk Index improved the C-statistic for MCE (from 0.675 to 0.712, <i>P</i> =0.018), with a net reclassification improvement of 0.428 (95% CI, 0.254-0.601, <i>P</i> &lt;0.0001). An ECCB ≥3 was associated with 2-fold higher adjusted odds of MCE versus an ECCB &lt;3 (adjusted odds ratio, 2.11 [95% CI, 1.42-3.12]). </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> CONCLUSIONS: Prevalence and severity of coronary calcium obtained from existing nongated chest CT imaging improve preoperative clinical risk stratification before nongated surgery.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37732454/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230924203716&v=2.17.9.post6+86293ac">37732454</a> | DOI: <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.064398>10.1161/CIRCULATIONAHA.123.064398</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37732454</guid><pubDate> Thu, 21 Sep 2023 06:00:00 -0400</pubDate><dc:creator> Daniel Y Choi</dc:creator><dc:creator> Dena Hayes</dc:creator><dc:creator> Samuel D Maidman</dc:creator><dc:creator> Nehal Dhaduk</dc:creator><dc:creator> Jill E Jacobs</dc:creator><dc:creator> Anna Shmukler</dc:creator><dc:creator> Jeffrey S Berger</dc:creator><dc:creator> Germaine Cuff</dc:creator><dc:creator> David Rehe</dc:creator><dc:creator> Mitchell Lee</dc:creator><dc:creator> Robert Donnino</dc:creator><dc:creator> Nathaniel R Smilowitz</dc:creator><dc:date> 2023-09-21</dc:date><dc:source> Circulation</dc:source><dc:title> Existing Nongated CT Coronary Calcium Predicts Operative Risk in Patients Undergoing Noncardiac Surgeries (ENCORES)</dc:title><dc:identifier> pmid:37732454</dc:identifier><dc:identifier> doi:10.1161/CIRCULATIONAHA.123.064398</dc:identifier></item><item><title> Cardiovascular Imaging in Contemporary Cardio-Oncology: A Scientific Statement From the American Heart Association</title><link/> https://pubmed.ncbi.nlm.nih.gov/37732422/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230924203716&amp;v=2.17.9.post6+86293ac<description> Advances in cancer therapeutics have led to dramatic improvements in survival, now inclusive of nearly 20 million patients and rising. However, cardiovascular toxicities associated with specific cancer therapeutics adversely affect the outcomes of patients with cancer. Advances in cardiovascular imaging have solidified the critical role for robust methods for detecting, monitoring, and prognosticating cardiac risk among patients with cancer. However, decentralized evaluations have led to a lack... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Circulation</b> . 2023 Sep 21. doi: 10.1161/CIR.0000000000001174. Online ahead of print.</p><p> <b>ABSTRACT</b> </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> Advances in cancer therapeutics have led to dramatic improvements in survival, now inclusive of nearly 20 million patients and rising. However, cardiovascular toxicities associated with specific cancer therapeutics adversely affect the outcomes of patients with cancer. Advances in cardiovascular imaging have solidified the critical role for robust methods for detecting, monitoring, and prognosticating cardiac risk among patients with cancer. However, decentralized evaluations have led to a lack of consensus on the optimal uses of imaging in contemporary cancer treatment (eg, immunotherapy, targeted, or biological therapy) settings. Similarly, available isolated preclinical and clinical studies have provided incomplete insights into the effectiveness of multiple modalities for cardiovascular imaging in cancer care. The aims of this scientific statement are to define the current state of evidence for cardiovascular imaging in the cancer treatment and survivorship settings and to propose novel methodological approaches to inform the optimal application of cardiovascular imaging in future clinical trials and registries. We also propose an evidence-based integrated approach to the use of cardiovascular imaging in routine clinical settings. This scientific statement summarizes and clarifies available evidence while providing guidance on the optimal uses of multimodality cardiovascular imaging in the era of emerging anticancer therapies.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37732422/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230924203716&v=2.17.9.post6+86293ac">37732422</a> | DOI: <a href=https://doi.org/10.1161/CIR.0000000000001174>10.1161/CIR.0000000000001174</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37732422</guid><pubDate> Thu, 21 Sep 2023 06:00:00 -0400</pubDate><dc:creator> Daniel Addison</dc:creator><dc:creator> Tomas G Neilan</dc:creator><dc:creator> Ana Barac</dc:creator><dc:creator> Marielle Scherrer-Crosbie</dc:creator><dc:creator> Tochi M Okwuosa</dc:creator><dc:creator> Juan C Plana</dc:creator><dc:creator> Kerryn W Reding</dc:creator><dc:creator> Viviany R Taqueti</dc:creator><dc:creator> Eric H Yang</dc:creator><dc:creator> Vlad G Zaha</dc:creator><dc:creator> American Heart Association Council on Cardiovascular Radiology and Intervention; Cardio-Oncology Committee of the Council on Clinical Cardiology and Council on Genomic and Precision Medicine; and Council on Cardiovascular and Stroke Nursing</dc:creator><dc:date> 2023-09-21</dc:date><dc:source> Circulation</dc:source><dc:title> Cardiovascular Imaging in Contemporary Cardio-Oncology: A Scientific Statement From the American Heart Association</dc:title><dc:identifier> pmid:37732422</dc:identifier><dc:identifier> doi:10.1161/CIR.0000000000001174</dc:identifier></item><item><title> CHIP in HF: prognostic role and cell-intrinsic effects</title><link/> https://pubmed.ncbi.nlm.nih.gov/37730906/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230924203716&amp;v=2.17.9.post6+86293ac<description> No abstract </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Nat Rev Cardiol. 2023 Sep 20. doi: 10.1038/s41569-023-00942-7. Online ahead of print.</p><p> <b>NO ABSTRACT</b></p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37730906/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230924203716&v=2.17.9.post6+86293ac">37730906</a> | DOI: <a href=https://doi.org/10.1038/s41569-023-00942-7>10.1038/s41569-023-00942-7</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37730906</guid><pubDate> Thu, 21 Sep 2023 06:00:00 -0400</pubDate><dc:creator> Karina Huynh</dc:creator><dc:date> 2023-09-21</dc:date><dc:source> Nature reviews. Cardiology</dc:source><dc:title> CHIP in HF: prognostic role and cell-intrinsic effects</dc:title><dc:identifier> pmid:37730906</dc:identifier><dc:identifier> doi:10.1038/s41569-023-00942-7</dc:identifier></item><item><title> Reply: Acetazolamide in Acute Decompensated Heart Failure</title><link/> https://pubmed.ncbi.nlm.nih.gov/37730297/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230924203716&amp;v=2.17.9.post6+86293ac<description> No abstract </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> J Am Coll Cardiol. 2023 Sep 26;82(13):e113. doi: 10.1016/j.jacc.2023.07.016.</p><p> <b>NO ABSTRACT</b></p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37730297/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230924203716&v=2.17.9.post6+86293ac">37730297</a> | DOI: <a href=https://doi.org/10.1016/j.jacc.2023.07.016>10.1016/j.jacc.2023.07.016</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37730297</guid><pubDate> Wed, 20 Sep 2023 06:00:00 -0400</pubDate><dc:creator> Frederik H Verbrugge</dc:creator><dc:creator> Pieter Martens</dc:creator><dc:creator> Wilfried Mullens</dc:creator><dc:date> 2023-09-20</dc:date><dc:source> Journal of the American College of Cardiology</dc:source><dc:title> Reply: Acetazolamide in Acute Decompensated Heart Failure</dc:title><dc:identifier> pmid:37730297</dc:identifier><dc:identifier> doi:10.1016/j.jacc.2023.07.016</dc:identifier></item><item><title> Acetazolamide in Acute Decompensated Heart Failure</title><link/> https://pubmed.ncbi.nlm.nih.gov/37730296/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230924203716&amp;v=2.17.9.post6+86293ac<description> No abstract </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> J Am Coll Cardiol. 2023 Sep 26;82(13):e111. doi: 10.1016/j.jacc.2023.06.048.</p><p> <b>NO ABSTRACT</b></p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37730296/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230924203716&v=2.17.9.post6+86293ac">37730296</a> | DOI: <a href=https://doi.org/10.1016/j.jacc.2023.06.048>10.1016/j.jacc.2023.06.048</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37730296</guid><pubDate> Wed, 20 Sep 2023 06:00:00 -0400</pubDate><dc:creator> Ramdas G Pai</dc:creator><dc:date> 2023-09-20</dc:date><dc:source> Journal of the American College of Cardiology</dc:source><dc:title> Acetazolamide in Acute Decompensated Heart Failure</dc:title><dc:identifier> pmid:37730296</dc:identifier><dc:identifier> doi:10.1016/j.jacc.2023.06.048</dc:identifier></item></channel></rss>